USE OF IRON-CHELATING COMPOUNDS, CYCLIC ADENOSINE MONOPHOSPHATE-INCREASING COMPOUNDS OR COMBINATIONS THEREOF FOR TREATING AXONAL LESIONS IN THE CNS

摘要

The invention relates to cell implants and/or at least one pharmaceutically acceptable compound selected from the group consisting of iron chelating agents, cyclic adenosine monophosphate level-increasing compounds (CASEV), axon growth promoting compounds, inhibitors of the intracellular Rho signal path or combinations thereof for producing a drug for protecting neurons in the CNS that are damaged by axonal lesion from being destructed.